The FDA removed semaglutide from its shortage list on February 21, 2025, and tirzepatide on December 19, 2024
Whether youre stopping Semaglutide (Ozempic, Wegovy), Tirzepatide (Mounjaro), or another GLP-1 medication due to side effects, cost, or personal choice, understanding how to discontinue safely can help you protect the progress youve worked so hard for
Antes de plantear un tratamiento farmacolgico, es necesario evaluar la adherencia y los resultados obtenidos con las intervenciones anteriores
After excluding prespecified weight-related and appetite-suppression terms, manual review found 91.0% positive predictive value and 98.6% recall for extracted side effects on a random sample of 100 self-use classified posts
Her care is built on deep listening and precision medicine, ensuring that each womans plan is designed for her unique needs
Some patients also explore alternative medications within the GLP-1 class